Jin Hwan Kim

Title: **Innovator Spotlight: Jin Hwan Kim**

Introduction

Jin Hwan Kim is a prominent inventor based in Daejeon, South Korea, known for his significant contributions to biotechnology. With a total of three patents, Kim has made notable advancements in the field of stable liquid formulations for therapeutic proteins, focusing on enhancing treatment options for various ophthalmic diseases.

Latest Patents

Kim’s latest patents showcase his expertise in the development of stable formulations. One noteworthy patent is titled "Stable Liquid Formulation of Fusion Protein with IgG Fc Domain." This invention includes a fusion protein that incorporates an Fc domain of human immunoglobulin G (IgG). It provides a stable liquid formulation suitable for the intravitreal injection of an anti-VEGF-Fc fusion protein, including aflibercept. This innovation aims to improve therapeutic effects on conditions caused by abnormal angiogenesis, such as retinal vein occlusion and diabetic macular edema.

Another significant patent is "Composition for Stabilizing Protein and Pharmaceutical Formulation Comprising the Same." This invention focuses on a composition designed to stabilize TNFα-binding protein, exhibiting key physiological activities. It incorporates basic amino acids and sugar and/or ammonium salts, effectively preventing aggregation, denaturation, and oxidation. This stability allows for long-term preservation of proteins vital for treating various diseases, further establishing Kim’s contributions to medical advancements.

Career Highlights

Throughout his career, Jin Hwan Kim has been associated with reputable companies, including Alteogen, Inc. and Crystalgenomics, Inc. His work at these institutions has enabled him to leverage his expertise in protein formulation and contribute to important advancements in biotechnology.

Collaborations

Collaboration has played an essential role in Kim’s journey as an inventor. He has worked alongside notable professionals, including Soon Jae Park and Hye-Shin Chung. Their combined efforts have led to innovative developments and have helped drive vital research in the biopharmaceutical field.

Conclusion

Jin Hwan Kim stands out as a distinguished inventor whose work in stabilizing protein formulations is making significant strides in therapeutic applications. With a focus on improving treatment methodologies for various conditions, Kim’s innovations continue to impact the medical landscape positively. His dedication to advancing biotechnology exemplifies the spirit of invention and the commitment to enhancing patient care.